Cash, groceries, alcohol, electronics, massages, medical equipment, and furniture allegedly rewarded beneficiaries for remaining enrolled, while prosecutors say important restrictions on curative coverage and physician certification were concealed from people recruited into hospice care.
WASHINGTON, DC — Federal prosecutors allege that a Southern California hospice operator turned living Medicare beneficiaries into recurring sources of revenue by offering monthly cash and an expanding catalog of consumer goods whenever patients agreed to remain enrolled in end-of-life care programs.
The accusations appear in a 16-count indictment against Oren David Shachar, Jeannie Choi, and Abraham Shin, whose alleged conspiracy connected four Los Angeles-area hospice companies, paid patient recruitment, misleading enrollment presentations, deceased beneficiaries’ identities, and approximately $27,731,000 in challenged Medicare claims.
Medicare allegedly paid approximately $26,908,000 to the four providers between 2021 and 2026, although that total covers the government’s entire theory and should not be described as money attributable exclusively to inducements given to living patients.
Every charge remains an allegation; all three defendants are presumed innocent unless prosecutors establish guilt beyond a reasonable doubt, and the indictment represents accusations approved by a grand jury rather than factual findings reached after evidence and defenses were tested at trial.
An Alleged Retention Marketplace Built Around Living Patients
The government’s federal indictment describing the alleged hospice conspiracy says Shachar personally met Medicare beneficiaries whom he allegedly knew were not terminally ill, then promoted his companies as providers of quality-of-life assistance rather than clearly presenting hospice as end-of-life care.
Prosecutors say Shachar and people working for him concealed that a physician needed to certify each beneficiary as terminally ill, a foundational eligibility requirement that ordinarily communicates the seriousness and medical purpose of electing the Medicare hospice benefit.
The indictment further alleges that prospective and enrolled beneficiaries were not told that accepting hospice services could affect Medicare payment for treatment furnished by other providers, including primary-care physicians, and could limit coverage for curative care related to the terminal condition.
Once beneficiaries entered the four hospices, Shachar allegedly paid them directly or through marketers as much as $400 a month while they remained enrolled, turning continued participation into a recurring financial decision rather than one based only on prognosis, informed consent, and treatment goals.
Cash was allegedly supplemented with groceries, alcohol, personal-care supplies, medical equipment, televisions, massages, furniture, and reclining armchairs, an assortment that could resemble ordinary household assistance while prosecutors characterize its purpose as purchasing continued access to federally reimbursable beneficiaries.
Why Continued Enrollment Allegedly Produced Continuing Revenue
Medicare hospice reimbursement generally continues while a qualifying beneficiary remains enrolled and documented services satisfy program rules, meaning a living patient can generate repeated claims across successive benefit periods rather than producing only one payment at the initial enrollment date.
Prosecutors allege that patient marketers sometimes received about $700 for each month a referred living beneficiary remained billed to Medicare, placing marketers and beneficiaries in parallel payment streams whose value depended on keeping the same patient attached to a Shachar hospice.
Under that alleged structure, the beneficiary could receive as much as $400 monthly while a marketer collected about $700 monthly, and the hospice could continue seeking Medicare reimbursement for purported services tied to an enrollment prosecutors say was medically unnecessary or improperly procured.
The indictment also says beneficiaries were offered another $100 or $200 for every person they referred for hospice enrollment, creating a secondary recruitment channel through trusted family, neighborhood, community, or social relationships that could expand the pool of billable patients.
Such an arrangement would reward retention and multiplication simultaneously, because remaining enrolled could produce monthly benefits while introducing another beneficiary could generate an immediate referral payment and potentially establish a new recurring reimbursement relationship for the provider and marketer.
Prosecutors will still need to prove that disputed transfers were intended as inducements and connected to federal healthcare business, since the presence of groceries, furniture, equipment, or cash alone does not establish who supplied an item, why it was provided, or what anyone understood.
What Medicare Hospice Election Actually Means
Medicare hospice care is generally available through Part A when physicians certify that a beneficiary is terminally ill, ordinarily meaning the person has a life expectancy of six months or less if the illness follows its expected course.
The beneficiary must also sign an election statement accepting palliative care instead of Medicare-covered treatment intended to cure the terminal illness and related conditions, making informed understanding essential because the election changes responsibility for clinically connected services, medications, and provider arrangements.
A hospice election does not erase every Medicare entitlement or prevent care for unrelated health conditions, but services connected to the terminal diagnosis are generally organized and covered through the hospice benefit, subject to important exceptions and beneficiary rights.
That distinction makes the alleged concealment especially consequential, because an enrollee could continue visiting familiar professionals and reasonably believe nothing important had changed, only to encounter payment complications when seeking treatment that Medicare or the hospice considered related to the terminal condition.
Beneficiaries retain the right to revoke hospice, return to ordinary Medicare coverage for the terminal illness, change hospice providers within applicable benefit-period rules, and later elect hospice again when they remain eligible and decide that comfort-focused care reflects their wishes.
Those rights depend upon accurate explanations rather than paperwork alone, since a signature obtained through assurances about free assistance, monthly payments, or routine wellness services may not reflect an informed choice if the person never understood the terminal certification or coverage consequences.
Gifts Can Blur the Boundary Between Care and Inducement
Hospice providers legitimately furnish medications, supplies, equipment, nursing, counseling, respite services, and other support related to palliation, so jurors may eventually need to distinguish covered patient care from items allegedly supplied primarily to secure enrollment or discourage departure.
A reclining chair or piece of medical equipment may improve comfort for a seriously ill person, while groceries and personal-care supplies may relieve household pressure, yet the government alleges these benefits were offered because beneficiaries stayed enrolled rather than because individualized clinical plans required them.
Televisions, massages, alcohol, and general furniture may create a different evidentiary impression, although prosecutors must still establish the purpose, source, timing, value, and recipient of particular benefits instead of asking jurors to infer criminal intent from a colorful list.
For beneficiaries with limited income, food insecurity, mobility challenges, or social isolation, a few hundred dollars and useful household goods can carry substantial influence, especially when recruiters present the arrangement as harmless assistance rather than compensation tied to a serious healthcare election.
The alleged inducements therefore raise questions extending beyond technical billing compliance, because a benefit can distort medical consent even when the recipient appreciates its immediate value and does not recognize that continued enrollment creates reimbursement consequences for taxpayers and treatment consequences for patients.
Concealed Coverage Consequences Could Affect Curative Treatment
Prosecutors allege that Shachar and others failed to disclose how hospice participation would affect Medicare benefits involving other providers and curative treatment, a claim that focuses the case upon what beneficiaries understood before and after they signed enrollment documents.
A patient who believes a hospice is simply offering extra nursing visits, household goods, or quality-of-life services may not realize that a terminal diagnosis has been entered, a hospice election has become active, and related treatment must flow through different coverage rules.
When primary-care clinicians, specialists, pharmacies, emergency departments, or medical equipment suppliers later submit claims, disagreements about whether treatment relates to the terminal illness can produce denials, redirection, delays, unexpected bills, or confusion among providers attempting to coordinate care.
The indictment does not publicly describe every beneficiary’s diagnosis, conversation, literacy, language, or resulting medical experience, leaving prosecutors to prove misrepresentation and medical ineligibility through individualized evidence rather than assuming every living enrollee received identical explanations or consequences.
Defense lawyers may argue that certain patients genuinely qualified for hospice, understood the election, received valuable palliative services, or obtained items consistent with compassionate care, while challenging whether statements made by independent recruiters can establish Shachar’s knowledge or intent.
Recruiters Allegedly Connected Patients, Payments, and Providers
The government describes patient marketers as essential intermediaries who located beneficiaries, facilitated enrollment, distributed benefits, and received referral-based compensation, allowing the alleged operation to reach patients through people who could appear more familiar and less institutional than hospice administrators.
Shin allegedly joined the conspiracy no later than March 2025, while Choi allegedly participated from no later than May 2025 through at least November 2025, meaning prosecutors assign different timeframes and cannot automatically treat every defendant as responsible for every earlier transaction.
Two substantive Anti-Kickback Statute counts accuse Shachar of offering and paying $300 to Choi for a living beneficiary referral during September 2025 and offering and paying another $300 to Shin for a referral during January 2026.
Those two alleged payments are narrower than the indictment’s broader description of monthly marketer compensation and patient inducements, illustrating why the charged transactions, overarching conspiracy allegations, and total Medicare claims must remain analytically separate throughout responsible coverage.
Communications, bank records, payment ledgers, patient files, device extractions, and witness testimony may help prosecutors establish whether compensation followed successful enrollments, increased with continued billing, or corresponded with promises made to beneficiaries about monthly money and household goods.
Defense counsel can scrutinize whether transfers represented permitted services, wages, reimbursements, charitable assistance, or unrelated transactions, while also challenging shared accounts, informal bookkeeping, witness credibility, and the assumption that every marketer used identical recruitment language.
Four Hospice Companies Formed the Alleged Network
The indictment collectively calls Gentle Touch Hospice Care in Valley Glen, Oxford Hospice Care in Montclair, Art of Hospice in Encino, and Holly Trinity Hospice in Glendale the Shachar Hospices, although each business maintained its own legal identity and Medicare enrollment.
Federal filings place Shachar’s alleged ownership or control of Art of Hospice as early as October 2019, Oxford during December 2020, Gentle Touch during February 2021, and Holly Trinity during April 2023, respectively.
Prosecutors say Shachar submitted at least 11 Medicare enrollment applications certifying that claims would concern medically necessary services provided as represented and would comply with federal prohibitions involving kickbacks, deliberate ignorance, reckless disregard, and materially false billing information.
Common control across several companies could help the government argue that repeated recruitment practices and payment arrangements reflected one coordinated plan, yet prosecutors must still connect particular claims, beneficiaries, transfers, employees, and representations with particular defendants and providers.
Across the four companies, approximately $27,731,000 in claims were allegedly submitted for care that was medically unnecessary, ineligible for payment, not provided as represented, or procured through kickbacks, while Medicare allegedly paid approximately $26,908,000 before the charged period ended.
The unusually high ratio between submitted and paid claims shows why authentic enrollment fields and clinically plausible records can be financially powerful, although a claim payment does not determine whether fraud occurred or establish any individual defendant’s knowledge.
Living Enrollments Allegedly Created a Statistical Problem
Hospice populations ordinarily include many patients who die while receiving end-of-life care, yet people can stabilize, improve, revoke their election, transfer providers, or leave alive, making a live discharge lawful and sometimes clinically appropriate rather than inherently suspicious.
Prosecutors allege that the Shachar Hospices enrolled so many living beneficiaries who were not terminally ill that their live-discharge patterns risked drawing attention from Medicare contractors, auditors, or investigators examining whether the companies were using the benefit for inappropriate long-term care.
The indictment says Shachar and others attempted to counter that signal by creating purported hospice episodes for recently deceased beneficiaries, thereby making their overall patient population appear to contain more people with genuine terminal needs and expected end-of-life outcomes.
That separate deceased-patient component allegedly involved purchased identifiers, backdated records, and payments to Choi and Shin, but its claimed statistical purpose began with the living-patient strategy and the conspicuous number of people who remained alive or left hospice care.
Medicare’s annual per-patient spending limitation supplied another alleged motive for adding deceased beneficiaries, because prosecutors say those files helped offset the financial effects of living patients who remained enrolled and generated claims across longer periods.
The alleged relationship between living and deceased enrollments suggests a scheme based on portfolio management rather than isolated claims, with one category producing recurring revenue while another purportedly adjusted outcome statistics and spending calculations that might otherwise expose the pattern.
The Human Cost Reaches Beyond Federal Spending
Hospice care supports pain control, symptom management, nursing, emotional counseling, spiritual support, caregiver respite, and dignified decision-making, so fraudulent enrollment can harm a benefit whose legitimacy depends upon exceptional trust among patients, families, clinicians, and government payers.
If beneficiaries were inaccurately labeled terminally ill, their electronic records could carry diagnoses, certifications, and care plans that influence later clinicians, insurers, pharmacies, family discussions, and personal decisions even after they revoke hospice or move to another provider.
Curative treatment could become harder to coordinate when coverage responsibility is misunderstood, while beneficiaries might delay seeking appropriate care because they were told hospice merely provided supportive benefits without changing how Medicare handles services connected with the alleged terminal condition.
Families could also experience anxiety after discovering that a relative accepted cash or goods, particularly when relatives encouraged enrollment without understanding the program, received referral payments themselves, or later confronted records suggesting a prognosis nobody had meaningfully explained.
Legitimate hospices face collateral damage whenever a major fraud case dominates public attention, because patients may begin distrusting outreach, questioning necessary comfort equipment, or declining appropriate end-of-life support out of fear that every provider profits from terminal certification.
How Patients Can Recognize Questionable Hospice Recruitment
Unsolicited promises of cash, groceries, furniture, housekeeping, electronics, or other personal rewards should prompt immediate caution when participation requires providing a Medicare number, signing medical documents, accepting a terminal diagnosis, or remaining with a particular hospice company.
Beneficiaries should understand who certified the prognosis, which illness supports eligibility, what services the hospice will provide, how related medications and treatment will be covered, which physician remains involved, and how to revoke the election if their goals change.
A trusted relative or independent clinician can help review the election statement before you sign, especially if recruiters minimize the meaning of hospice, describe enrollment as ordinary home assistance, promise valuable goods, or discourage questions about terminal illness and curative care.
Medicare statements and claim summaries can reveal unfamiliar hospice services, while pharmacies, specialists, or primary-care offices may notice unexpected coverage changes that should be investigated promptly with the beneficiary, the hospice, Medicare, and appropriate fraud-reporting channels.
Patients should not be blamed for accepting help offered during financial or medical vulnerability, because professionals and organizations seeking federal reimbursement through their enrollment decisions bear primary responsibility for truthful explanation, lawful billing, medical necessity, and compliant marketing.
Data Analytics Can Expose Retention Patterns
Investigators can compare each hospice’s length-of-stay distribution, live-discharge rate, referral concentration, marketer compensation, benefit periods, service intensity, patient diagnoses, revocation history, and place of death with similarly situated providers across the same region.
Recurring transfers near enrollment dates, repeated payments in round amounts, or compensation continuing while a beneficiary remains billed can become especially significant when matched with messages discussing groceries, televisions, furniture, referral bonuses, or requests to keep patients from leaving.
Electronic records can show who entered a certification, when a note was created, whether a face-to-face encounter occurred, which device accessed a chart, and whether documentation changed after Medicare questions, patient complaints, revocations, or deaths.
Patient interviews provide context that claim data cannot, because beneficiaries can describe what recruiters promised, whether anyone discussed terminal illness, which goods arrived, who delivered cash, what services were actually received, and whether attempts to leave generated pressure or additional offers.
Effective oversight must still avoid treating unusual data as automatic guilt, since legitimate hospices serving complex populations can show atypical patterns, and sound investigations require medical review, documentary verification, witness testing, and transaction-level proof rather than statistical suspicion alone.
The Charges Extend Beyond Patient Inducements
Count one charges all three defendants with conspiracy to commit healthcare fraud, while counts two through nine identify particular alleged executions of healthcare fraud involving claims submitted through the four providers between August 2023 and November 2025.
Counts ten through twelve allege aggravated identity theft involving deceased beneficiaries, count thirteen concerns a $15,000 transaction connected with an alleged Rolls-Royce Phantom arrangement, and counts fourteen and fifteen concern the two alleged $300 referral payments.
Count sixteen separately accuses Shachar of selling or distributing nine Medicare beneficiary identifiers to an unnamed physician for $12,500 during March 2025, broadening the case beyond hospice retention and alleging that protected patient information itself became a traded commodity.
Contemporary FOX 11 Los Angeles reporting on the federal healthcare fraud takedown described the alleged patient kickbacks within a nationwide enforcement campaign, while emphasizing that several details about affected beneficiaries and associated funeral-industry access remained undisclosed publicly.
If convictions occur, the combination of healthcare fraud, aggravated identity theft, monetary-transaction, kickback, and beneficiary-identifier charges could carry severe penalties, but possible statutory exposure does not predict conviction or the sentence any judge would ultimately impose.
Shachar, 59, of Van Nuys, and Shin, 66, of Corona, were arrested June 18 and released on bond after initial proceedings, while Choi, 57, of Torrance, was arrested several days later, according to the Justice Department.
Medical Disputes and Intent Will Shape the Defense
Hospice eligibility frequently depends upon difficult clinical judgments made when illness trajectories remain uncertain, allowing defense lawyers to argue that survival beyond six months, improvement, or eventual live discharge does not prove an original terminal prognosis was knowingly false.
The government’s case extends beyond prognosis disagreements, however, because prosecutors also allege concealed coverage consequences, monthly cash, consumer goods, referral bonuses, compensation linked to continued billing, backdated records, and purchases of deceased beneficiaries’ identifying information.
Jurors may therefore be asked to determine whether recurring patterns reveal knowing deception or whether the evidence reflects inconsistent employees, aggressive but misunderstood marketing, lawful patient support, disputed medical judgments, poor documentation, and transactions lacking the criminal meaning prosecutors assign.
Evidence concerning one beneficiary cannot automatically establish what happened with another, while evidence involving one hospice or marketer may require careful limits when jurors evaluate defendants who allegedly joined in different years and held different roles within the broader operation.
The most persuasive proof may arise where independent evidence converges, such as a beneficiary describing a monthly payment, a message promising that amount, a matching bank withdrawal, continued Medicare billing, and records showing no terminal condition or meaningful hospice services.
Conversely, missing communications, legitimate clinical documentation, credible explanations for goods, or evidence that particular defendants lacked knowledge could weaken portions of the government’s theory, making transaction-by-transaction analysis more important than the disturbing overall narrative.
Public Allegations Create a Separate Reputation Crisis
Healthcare fraud accusations can damage a professional or company before trial because headlines involving vulnerable seniors, alcohol, televisions, dead beneficiaries, and luxury vehicles travel faster than evidentiary qualifications, while search results preserve the allegations long after procedural developments occur.
Amicus International Consulting’s framework for crisis public-relations planning during damaging publicity emphasizes organized risk assessment and consistent communication, although any public response in an active criminal case must remain coordinated with defense counsel and must never interfere with witnesses or evidence.
Accurate communication should acknowledge filed allegations, explain the presumption of innocence, correct provable errors, avoid attacking beneficiaries, and distinguish separate defendants or companies without issuing sweeping denials that later records, testimony, or plea negotiations could contradict.
Longer-term reputation rebuilding after a public crisis may require transparent remediation, independently verified compliance changes, accurate search content, and sustained conduct, but reputation management cannot replace courtroom advocacy or erase facts ultimately established through lawful proceedings.
Responsible news coverage carries a comparable duty by describing the indictment’s details without declaring guilt, separating alleged patient payments from ordinary hospice benefits, and explaining that the aggregate claims figure includes several distinct theories rather than one uniform transaction.
Part of a Record National Enforcement Campaign
The Shachar case was announced during the 2026 National Health Care Fraud Takedown, which federal authorities described as involving 455 defendants, including 90 licensed medical professionals, across 56 judicial districts and more than $6,500,000,000 in alleged false claims.
Authorities also reported more than $182,000,000 in seized cash, vehicles, real estate, and luxury property, alongside administrative payment suspensions and billing-privilege revocations that can disrupt healthcare businesses before criminal charges are resolved through pleas, dismissals, or trials.
National totals show enforcement scale but prove nothing about these three defendants, because prosecutors must establish the elements of each count with admissible evidence tied to the Shachar Hospices rather than relying on unrelated schemes included in the same government announcement.
The Federal Bureau of Investigation and the Department of Health and Human Services Office of Inspector General are investigating, while a Justice Department trial attorney is prosecuting the case through the federal healthcare fraud enforcement structure in Los Angeles.
What Happens Next
Pretrial litigation may address voluminous discovery, medical experts, electronic-record authentication, patient privacy, financial tracing, admissibility of marketing communications, severance among defendants, forfeiture restraints, and whether evidence from one hospice can be considered against another participant.
Living beneficiaries may become pivotal witnesses because they can explain what they were told, whether they understood hospice, which inducements they received, how long payments continued, who delivered benefits, and whether anyone discouraged them from revoking enrollment or seeking curative treatment.
Clinicians and billing employees may testify about terminal certifications, service delivery, chart access, claim submission, and company control, while financial records could show whether Medicare payments funded marketer compensation, beneficiary benefits, operating expenses, or the luxury transaction described in the indictment.
Until evidence is tested and the charges are resolved, the case remains a detailed allegation that a benefit designed for compassionate end-of-life care became a marketplace where living patients, referrals, and continued enrollment carried monthly prices.
Its broader significance will depend upon whether prosecutors prove that cash and household assistance were knowingly used to purchase medically unnecessary hospice participation while concealing coverage consequences, rather than merely demonstrating that unconventional benefits, disputed diagnoses, and aggressive marketing existed around reimbursed care.
